Mid Cap Biotechnology
Stocks Ranked by
Market Capitalization

Biotech and biopharmaceutical companies engaged in research, discovery, development, and production of innovative drug and drug- related technologies.

#	Name	Market cap	Price	Price change %
51	51 ImmunityBio IBRX $2.61B	$2.61B	$2.76	1.78%
52	52 Viking Therapeutics VKTX $2.6B	$2.6B	$23.09	2.53%
53	53 Amicus Therapeutics FOLD $2.46B	$2.46B	$7.97	0.5%
54	54 Catalyst Pharmaceutical CPRX $2.45B	$2.45B	$20.02	0.25%
55	55 Celcuity CELC $2.32B	$2.32B	$54.60	2.88%
56	56 Beam Therapeutics BEAM $2.27B	$2.27B	$22.45	2.01%
57	57 Apogee Therapeutics APGE $2.24B	$2.24B	$37.63	2.14%
58	58 Liquidia Corp LQDA $2.24B	$2.24B	$25	3.96%
59	BLTE 59 Belite Bio BLTE $2.2B	$2.2B	$73	9.12%
60	60 Tarsus Pharmaceuticals TARS $2.18B	$2.18B	$51.69	2.15%
61	61 Ocular Therapeutix OCUL $2.16B	$2.16B	$12.16	2.25%
62	62 IDEAYA Biosciences IDYA $2.14B	$2.14B	$24.44	1.13%
63	63 Agios Pharmaceuticals AGIO $2.12B	$2.12B	$36.42	0.82%
64	64 Galapagos GLPG $2.11B	$2.11B	$32.26	0.75%
65	65 Disc Medicine IRON $2.1B	$2.1B	$61.03	1.14%
66	66 Recursion Pharmaceuticals RXRX $2.06B	$2.06B	$4.71	2.69%
67	67 Arcutis Biotherapeutics ARQT $2.06B	$2.06B	$17.14	1%
68	68 Travere Therapeutics TVTX $2.03B	$2.03B	$23.65	3.86%